NSE · JUBLINGREA
Jubilant Ingrevia Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹1,253 Cr with net profit ₹126 Cr — a 10.08% net margin, versus 6.28% the period before.
Shareholding
As of 2026-06-30
- Promoter45.22%
- Public23.3%
- FII6.49%
- DII24.98%
1,10,949 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.48× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Chemicals · ranked #22 of 159 by market cap · medians across 49 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Solar Industries India Ltd. | ₹1,69,805 Cr | 85.27 | 27.05 | 26.72% | 17.54% |
| Pidilite Industries Ltd. | ₹1,58,575 Cr | 59.87 | 14.64 | 22.61% | 17.2% |
| SRF Ltd. | ₹74,998 Cr | 33.47 | 5.34 | 13.07% | 13.01% |
| Linde India Limited | ₹52,019 Cr | 95.2 | 12.19 | 12.87% | 20.59% |
| Gujarat Fluorochemicals Ltd. | ₹49,113 Cr | 79.51 | 6.28 | 7.13% | 11.41% |
| Navin Fluorine International Ltd. | ₹42,252 Cr | 53.13 | 10.63 | 16.69% | 21.73% |
| Godrej Industries Ltd. | ₹37,956 Cr | 31.02 | 3.4 | 11.1% | 5.06% |
| Himadri Speciality Chem Limited | ₹32,971 Cr | 41.25 | 7.01 | 15.96% | 16.07% |
| Deepak Nitrite Ltd. | ₹21,887 Cr | 27.63 | 3.75 | 9.43% | 9.13% |
| Aether Industries Limited | ₹21,560 Cr | 89.85 | 8.78 | 8.94% | 19.11% |
| Jubilant Ingrevia Limited(this company) | ₹10,090 Cr | 31.74 | 3.15 | 8.89% | 6.7% |
AI analysis
AI-generated · google/gemini-2.5-flashJubilant Ingrevia Limited is listed with a market capitalization of Rs 11737 Cr. The company reported revenue of Rs 4215.43 Cr and a profit margin of 6.4%. Its P/E ratio is 134.71, and it has an EPS of Rs 18.06. The 52-week high for the share price was Rs 845.55, and the 52-week low was Rs 537.3.
Positives
- +Revenue grew 1% to Rs 4215.43 Cr annually.
- +The debt-to-equity ratio is 0.27, indicating low leverage.
- +The company maintains a dividend yield of 34%.
Negatives
- −Promoter shareholding decreased from 50.68% in March 2021 to 45.22% in June 2026.
- −9.3% of promoter shares are pledged as of June 30, 2026.
- −The profit margin is 6.4%, which is relatively thin.
- −The P/E ratio is 134.71, which is high.
Financial Performance
Jubilant Ingrevia Limited reported revenue of Rs 4215.43 Cr in the fiscal year ending March 2025, with a revenue growth rate of 1%. The company's net profit for the same period was Rs 251.182 Cr. Quarterly revenue for March 2026 was Rs 1178.65 Cr with a net profit of Rs 86.44 Cr. For the quarter ending December 2025, revenue was Rs 1050.91 Cr with a net profit of Rs 46.9 Cr.
Profitability & Returns
The company's profit margin stands at 6.4%. Return on equity (ROE) is 8.89%, and return on capital employed (ROCE) is 10.37%. The earnings per share (EPS) for the latest reported annual period is Rs 18.06. The company also offers a dividend yield of 34%.
Balance Sheet
Jubilant Ingrevia Limited maintains a debt-to-equity ratio of 0.27, indicating a relatively low reliance on debt financing. The book value per share is Rs 196.28.
Ownership & Pledges
As of June 30, 2026, promoter holding in Jubilant Ingrevia Limited was 45.22%. Foreign Institutional Investors (FIIs) held 6.49%, while Domestic Institutional Investors (DIIs) held 24.98%. Public shareholding was 23.30%. A total of 9.3% of promoter shares are pledged. The promoter shareholding has decreased from 50.68% in March 2021 to 45.22% in June 2026.
Data as of — price: 2026-09-17 · financials: Jun 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.